The news earlier this week that Miami Cancer Institute (MCI), one of the new hybrid academic-community cancer centers, had joined Memorial Sloan Kettering Cancer Center’s Cancer Alliance, was only the current evidence that this emerging model for delivering oncology care won’t merely be a flash in the pan.
When MedPage initial spoke along with the cancer focus directors last summer, these centers’ directors indicated that their respective programs were expanding and grabbing brand-new academic heights for community-based institutions. In interviews conducted this past week, they spoke of their continuing victory in forging links along with various other centers and in recruiting brand-new physicians.
Christiana’s Graham Cancer Center
Nicholas J. Petrelli, MD, the Bank of America-endowed medical director of Christiana Care Good health System’s Helen F. Graham Cancer focus and Research Institute in Newark, Del. — that established the initial hybrid focus As soon as he left Roswell Park Cancer Institute in the early 2000s to join the Graham focus — told MedPage Today that his focus and the Wistar Institute in Philadelphia, an NCI-designated straightforward science cancer focus in nearby Philadelphia, had met along with National Cancer Institute officials this past fall.
Wistar’s NCI grant renewal will certainly be in 2018, and its president and CEO Dario C. Altieri, MD, and Petrelli discussed a collaborative effort between the straightforward focus and Christiana’s clinical and translational programs to achieve either NCI clinical focus or comprehensive status.
During a telephone interview, Petrelli said that the 2 he and Altieri appreciate the value of high-risk, high-obtain translational research and that by combining resources they could achieve a synergy similar to that of existing NCI clinical centers.
“Dario said that cancer focus science is a continuum and as such it entails validating discoveries in patients, which is where the Graham focus comes in,” Petrelli said, adding that this additionally gets in to the issue of exactly how NCI straightforward science centers Can easily produce value in the era of precision medicine.
He said that they’ve additionally produced a unified IRB; a data-management system for transmitting patient data under HIPPA, IRB, and federal regulations; and established a tissue procurement transport system, and a steering committee.
As a collaborative example, Petrelli explained that the discovery of a gene as a circulating biomarker for non-small cell lung cancer by a Wister scientist is being used to test patients in an IRB-approved protocol at Graham too as in a statewide Delaware lung-cancer screening program.
Carolinas’ Levine Cancer Institute
Derek Raghavan, MD, PhD, president of Carolinas HealthCare System’s Levine Cancer Institute in Charlotte, N.C., told MedPage Today that in addition to concerning 150 professionals he has actually already recruited, he’s hoping to authorize on a prominent palliative care physician to head the Institute’s expanding medical support services department that entails palliative care, survivorship services, integrative medicine, cancer rehabilitation, psycho-oncology, and various various other supportive-oncology and patient-centered programs. The infusion focus additionally has actually an artist-in-house that works along with patients receiving chemotherapy.
A proponent of value in healthcare, he said that his philosophy is not to have actually a centripetal entity however quite a centrifugal entity and that is why he will certainly be asking for the construction of a second building on the Charlotte campus to home the growing variety of programs, in addition to those at 15 various sites throughout the Carolinas system.
Levine’s clinical trials routine has actually expanded throughout the region, its bio-repository Can easily take sample from various sites, and the Institute recently joined the Caris Centers of Excellence for Precision Medicine Network and is involved in molecularly-steered studies.
various other areas of growth consist of expanding clinical trials along with much more investigator-initiated and early phase trials; brand-new service lines including endocrine oncology; expanded programs in head and neck cancer, bone marrow transplantation, sickle cell, and multiple myeloma; and standardizing nursing and pharmaceutical method throughout the system.
“I am most pleased along with our pattern of rapid growth and expansion free of losing quality or our concentrate on patients and their families,” Raghavan said, noting that the institute and its staff have actually become heavily involved in Charlotte community tasks including the symphony, opera, and ballet.
Inova’s Schar Cancer Institute
Donald L. (Skip) Trump, MD (no relation to billionaire and presidential candidate Donald J. Trump), merely completed his initial year as CEO and executive director of the Inova Dwight and Martha Schar Cancer Institute in northern Virginia, after stepping down as president of Roswell Park Cancer Institute.
He told MedPage Today Throughout a phone interview that he’s been recruiting academic-based clinicians and researchers, and is expanding the women’s Good health focus about a gynecology oncology program.
“My mission is to establish a robust clinical trials routine that will certainly partner along with [former NCI director] John Niederhuber [MD] that is executive vice president and CEO of Inova’s Translational Medicine Institute (TMI) to take genomics in to clinical method for cancer,” he said.
Inova is concerning to launch its initial molecular tumor board, and will certainly be integrating genomics and genetic counseling.
Trump said that the Institute will certainly have the ability to take on clinical trials and offer incredible clinical care that supports patients and uses the resources available in genomics through TMI as a platform for target definition, target discovery, and biomarker discovery that could be married along with pharmacology.
“My greatest desire is to recruit a tough person at the interface between target discovery and synthesis screening and drug development, allowing us to collaborate along with industry, offer small bio-techs a source to insight design their drugs, and maybe even enable us, if we’re lucky, to produce our own drugs based on the discovery and development paradigm.”
Trump said there are plans for a brand-new ambulatory cancer focus to be retrofitted from the 240,000 square-foot former Exxon-Mobil headquarters across from Inova’s flagship hospital in Fairfax, Va., and that he plans to start producing fellowship programs in medical and surgical oncology.
Spartanburg’s Gibbs Cancer Center
Timothy Yeatman, MD, director of the Gibbs Cancer Center and president of Gibbs Research Institute at the Spartanburg, S.C., Regional Healthcare System, said Throughout a telephone interview that his vision of building a focus where function follows form is coming to fruition along with the construction of a multistory facility that will certainly support 10 multidisciplinary groups housed with each other by cancer site quite compared to by oncology specialty.
“We will certainly have actually disease-focused floors that follow a patient-centered model of cancer care along with doctors interacting in the clinic and facilitating much more curbside consulting,” he said, citing as an example a melanoma group that entails a surgical oncologist, medical oncologist, radiation oncologist, dermatologist, and plastic surgeon functioning together.
Yeatman said he was encouraging much more medical oncologists to participate in clinical trials by equalizing payment for their time, and was seeing an boost in molecular testing in patients while asking the question “that ought to and ought to not be tested,” resulting in a testing approach based on the risk of recurrence of the disease.
He said that the Guardian Research Network — described as a Good health IT ecosystem — has actually been a growing network of networks, and now entails much more compared to 80 hospitals from concerning half-a-dozen units across 11 states, including its initial NCI-designated comprehensive cancer focus member at Wake Forest Baptist Medical Center in Winston-Salem, N.C.
Guardian collects big data and aggregates patient clinical and molecular profiles in to a centralized system that Can easily offer accrual on necessity for industry trials, according to Yeatman, that is additionally producing a federated clearing home for tissues, and an imaging archives.
He said that by going out in to communities and networking them using the rule that big data amplifies the energy of networking, he has actually been able to “spread the gospel concerning the hybrid academic-community cancer focus concept.”
“I’ve discovered closet academicians [in community cancer settings] that constantly wanted to participate in research and never ever knew how, and offered the opportunity, wish to participate,” he said.
0 comments
Post a Comment